louisiana glp-1 gastroparesis class action Novo Nordisk is suing Eli Lilly over its ads, accusing the rival drugmaker of false advertising for claiming Lilly's Mounjaro and Zepbound outperform Novo's Ozempic and Wegovy. MORE BELOW ⬇️ glp-1 gastric intestinal obstruction attorney

GST is able specifically to bind to GSH or GSH analogs via the G-site, which catalyzes the interaction between GST amino-acid residues with GSH sulfhydryl and conventional electrophilic substances at the H-sites to promote catalytic action

James SH, Kimberlin DW, Whitley RJ

Demonstrating clinical benefit across a wider spectrum of diseases enhances the perceived value and utility of GLP-1 AOMs, and broadens its eligible patient population, facilitating improved outcomes for more individuals

Drago, F., Ciccarese, G., Cogorno, L., Calvi, C., Marsano, L

PMID 16214343

Dolezalova, P., Krijt, J., Chladek, J., Nemcova, D